Log in  First Connection?
  
EnglishJapaneseFrenchSpanishGerman

LungArchives

Complications following small-molecule inhibitors for non-small cell lung cancer
Lung
 1 min.

 Published on 19/05/2026 |  Original article (Full-text)  | Caroline Kamali et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2665836

Targeted therapies for oncogene-driven non–small cell lung cancer (NSCLC) have transformed precision oncology by enabling treatment tailored to specific molecular alterations and substantially improving outcomes in advanced disease. However, these agents are associated with distinct patterns of...

HTML version PDF version  Print abstract

Pembrolizumab trough concentration monitoring and association with outcomes in advanced non-small cell lung cancer
Lung
 1 min.

 Published on 12/05/2026 |  Original article (Full-text)  | Ioannis P. Trontzas et al. | Expert Review of Anticancer Therapy 2026; aop:10.1080/14737140.2026.2668466

Therapeutic drug monitoring (TDM) of immune checkpoint inhibitors (ICIs) remains limited due to drug-related challenges; however, a better understanding of exposure–effect relationships may improve antitumor activity and reduce immune-related adverse events (irAEs). We conducted a prospective TDM...

HTML version PDF version  Print abstract

Sex-based differences in effectiveness of immune checkpoint inhibitors in the treatment of advanced non-small-cell lung cancer: systematic review and meta-analysis
Lung
 7 min.

 Published on 05/05/2026 |  Original article (Full-text)  | Erick Suazo-Zepeda et al. | Thorax 2026; aop:10.1136/thorax-2025-223372

Data are available upon reasonable request. Data are available upon reasonable request. Data and code are available on request from ES-Z at e.suazo.zepeda@umcg.nl. https://creativecommons.org/licenses/by-nc/4.0/...

HTML version PDF version  Print abstract

Does Robotic Surgery Offer Advantages Over Thoracoscopic Surgery for Patients Undergoing Wedge Resection for Non-Small Cell Lung Cancer?
Lung
 1 min.

 Published on 28/04/2026 |  Original article (Full-text)  | Grace Ha et al. | European journal of cardio-thoracic surgery. Volume 68(3).

Wedge resection by video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) are minimally invasive techniques commonly used in non-small cell lung cancer management. Although RATS has been increasingly adopted for anatomical lung resections, it is unclear whether...

HTML version PDF version  Print abstract

Subcutaneous atezolizumab for the treatment of non-small cell lung cancer
Lung
 1 min.

 Published on 21/04/2026 |  Original article (Full-text)  | Jaime González-Montero et al. | Therapeutic Delivery 2026; 17(3): 249-258

Subcutaneous atezolizumab (with rHuPH20) streamlines anti–PD-L1 delivery while preserving the intravenous (IV) formulation's performance. This review integrates pharmacokinetic, clinical, safety, patient-reported, and operational data from IMscin001 and related studies in NSCLC. A fixed 1,875-mg...

HTML version PDF version  Print abstract